Clinical Trials Logo

Clinical Trial Summary

The Lumerah System, developed and manufactured by Raydiant Oximetry, Inc., is a non-invasive fetal pulse oximeter that measures fetal arterial oxygen saturation using safe, non-invasive, transabdominal near-infrared spectroscopy. The Lumerah System is intended as an adjunct to cardiotocography. In this study, women in labor will also be simultaneously monitored with a re-engineered version of the previously approved transvaginal oximeter sensor connected to a Nellcor N-400 fetal oximetry monitor for the purposes of device development. The data obtained from the transabdominal sensor and the transvaginal sensor will be used for research purposes only and will not be used to guide or alter patient management.


Clinical Trial Description

This is a prospective, interventional, open-label, Early Feasibility Study Investigational Device Exemption (EFS-IDE). The Principal Investigator or research team member will consult a list of eligible patients based on predicted delivery dates and scheduled inductions. Women who are planning to undergo labor will be approached regarding this study. The study involves measurement of the fetal pulse signal with the investigational device, Lumerah, during labor. Lumerah is an investigational fetal pulse oximeter that measures fetal arterial oxygen saturation using safe, non-invasive, transabdominal near-infrared spectroscopy. The Lumerah device is intended as an adjunct to cardiotocography by detecting fetal oxygen deprivation that is both life-threatening to the fetus and can lead to the irreversibly debilitating consequences of newborn metabolic acidosis. The subjects will first undergo sonographic evaluation to assess distance from maternal skin to fetal tissue and to confirm fetal presentation and position during labor. The results of the sonographic measurements might influence the enrollment suitability of the subject as well as the placement of the Investigational device. The Oxiplex TS device, a non-ionizing laser system that provides researchers with valuable information regarding maternal optical tissue properties, will also be used. Once the membranes are ruptured, the investigator's team will use a Nellcor N-400 System with a sterile, single-use transvaginal sensor for data collection only. The outcomes of the fetal oxygenation measurements are masked; only the Sponsor is aware of the measurements. Therefore, no clinical decisions will be made based on the information derived from any of the devices used in this study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06405984
Study type Interventional
Source Raydiant Oximetry, Inc.
Contact Kristin Ayers, MPH
Phone 757.446.0529
Email ayerskl@evms.edu
Status Recruiting
Phase Early Phase 1
Start date April 15, 2024
Completion date December 2024

See also
  Status Clinical Trial Phase
Completed NCT04597983 - Effect of 8-week Intake of 2S-hesperidin on Performance, Body Composition and Biochemicals Markers in Amateur Cyclists N/A
Recruiting NCT05858463 - High Intensity Interval Training and Muscle Adaptations During PR N/A
Completed NCT03331471 - Alveolar Recruitment Maneuver During Pneumoperitoneum N/A
Completed NCT04626453 - Oxygenation Changes After 2-month Exercise in Sedentary Older Adults With Diabetes N/A
Enrolling by invitation NCT04322994 - THRIVE Use in Pediatric Populations- Multi Site N/A
Not yet recruiting NCT05578131 - High-flow Nasal Cannula for Pediatric Anesthetic Induction N/A
Completed NCT05677009 - Sustainable Preservation of Essential Oxygen Resources: A Phase 4 Crossover Study of the BUFEO System: SAVE O2 N/A
Completed NCT04612270 - Quantification of Clinically Relevant Drug Induced Changes in HbO2 Affinity N/A
Completed NCT04584788 - Validation of the O3 Regional Somatic Tissue Oxygenation Monitor N/A
Recruiting NCT04141956 - Incidence of Use of High-Flow Nasal Cannula Oxygen Therapy in Intensive Care Units Patients
Completed NCT04973046 - Tissue Oxygen Saturation for Esophagectomy
Terminated NCT03665259 - Lower Inspiratory Oxygen Fraction for Preoxygenation N/A
Recruiting NCT03396172 - FreeDom: Innovative Strategy for the Management of COPD Exacerbations N/A
Completed NCT03128372 - Validation of Next Generation Cerebral and Tissue Oximeter N/A
Completed NCT05430724 - The Effects of Nicardipine and Esmolol Applied for Controlled Hypotension N/A
Recruiting NCT05783050 - Wei Nasal Jet Tube vs Nasal Cannula Oxygen Support in Gastrointestinal Endoscopy Patients N/A
Completed NCT04711317 - Pre-oxygenation With High-flow Nasal Cannula in Caesarian Section Under General Anesthesia N/A
Completed NCT03185507 - The Effect of Cryotherapy on Cerebral Hemodynamics Within Healthy Subjects Phase 1
Completed NCT04266665 - Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome Phase 4
Completed NCT06371651 - Creatine and GAA for Brain Oxygenation N/A